Time restricted eating for Marijuana Abuse

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Marijuana Abuse+3 More
Time restricted eating - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether time-restricted eating can improve symptoms in people with POTS, which is a condition characterized by fatigue, lightheadedness, and tachycardia.

Eligible Conditions
  • Marijuana Abuse

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: Change from Baseline quality of life questionnaire at 14 weeks

Week 14
Assess whether POTS patients demonstrate persistent inflammatory responses and immune cell exhaustion
Exploratory Outcome: Assess whether POTS patients demonstrate persistent inflammatory responses and immune cell exhaustion
Week 14
Characterize mitochondrial function in POTS patients
Exploratory Outcome: Characterize mitochondrial function in POTS patients
Week 14
Conduct a pilot clinical trial with POTS patients to assess if TRE can improve Quality of Life.

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Time restricted eating
1 of 1

Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Time restricted eating · No Placebo Group · N/A

Time restricted eating
Behavioral
Experimental Group · 1 Intervention: Time restricted eating · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time restricted eating
2018
N/A
~50

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline quality of life questionnaire at 14 weeks

Who is running the clinical trial?

Dysautonomia InternationalOTHER
5 Previous Clinical Trials
421 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,013 Previous Clinical Trials
1,794,027 Total Patients Enrolled
10 Trials studying Marijuana Abuse
1,007 Patients Enrolled for Marijuana Abuse
Taylor Doherty, MDPrincipal InvestigatorProfessor of Medicine
Pam Taub, MDPrincipal InvestigatorProfessor of Medicine
5 Previous Clinical Trials
391 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are between the ages of 18 and 65 years old.\n
You have a heart rate of at least 110 beats per minute when you are in a supine position and at least 100 beats per minute when you are in an upright position.
Associated with symptoms that are worse with upright posture and that improve with recumbency.
You have a minimum of 12-hour eating period, with a minimum of two meals per day.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: November 7th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
California100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Altman Clinical and Translational Research Institute100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria50.0%
Met criteria50.0%